Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC

NCT05077839 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

184

Enrollment

OTHER

Sponsor class

Conditions

First-line Treatment
Advanced Colorectal Cancer

Interventions

DRUG: Trifluridine/Tipiracil

Sponsor

Tianjin Medical University Cancer Institute and Hospital